Does ROSUVASTATIN Cause Nasal polyps? 27 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Nasal polyps have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.1% of all adverse event reports for ROSUVASTATIN.
27
Reports of Nasal polyps with ROSUVASTATIN
0.1%
of all ROSUVASTATIN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Nasal polyps From ROSUVASTATIN?
Of the 27 reports, 1 (3.7%) required hospitalization, and 1 (3.7%) were considered life-threatening.
Is Nasal polyps Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Nasal polyps?
DUPILUMAB (1,391)
ALBUTEROL (915)
PREDNISONE (780)
MEPOLIZUMAB (702)
MONTELUKAST (622)
OMALIZUMAB (544)
BUDESONIDE\FORMOTEROL (486)
TIOTROPIUM (400)
BUDESONIDE (397)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (311)
Which ROSUVASTATIN Alternatives Have Lower Nasal polyps Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN